Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Viktoria Gusarova
  • Colm O'Dushlaine
  • Tanya M. Teslovich
  • Peter N. Benotti
  • Tooraj Mirshahi
  • Omri Gottesman
  • Cristopher V. Van Hout
  • Michael F. Murray
  • Anubha Mahajan
  • Jonas B. Nielsen
  • Lars Fritsche
  • Anders Berg Wulff
  • Daniel F. Gudbjartsson
  • Marketa Sjögren
  • Connor A. Emdin
  • Robert A. Scott
  • Wen Jane Lee
  • Aeron Small
  • Lydia C. Kwee
  • Om Prakash Dwivedi
  • Rashmi B. Prasad
  • Shannon Bruse
  • Alexander E. Lopez
  • John Penn
  • Anthony Marcketta
  • Joseph B. Leader
  • Christopher D. Still
  • H. Lester Kirchner
  • Uyenlinh L. Mirshahi
  • Amr H. Wardeh
  • Cassandra M. Hartle
  • Lukas Habegger
  • Samantha N. Fetterolf
  • Teresa Tusie-Luna
  • Andrew P. Morris
  • Hilma Holm
  • Valgerdur Steinthorsdottir
  • Patrick Sulem
  • Unnur Thorsteinsdottir
  • Jerome I. Rotter
  • Lee Ming Chuang
  • Scott Damrauer
  • David Birtwell
  • Chad M. Brummett
  • Amit V. Khera
  • Pradeep Natarajan
  • Marju Orho-Melander
  • Jason Flannick
  • Luca A. Lotta
  • Cristen J. Willer
  • Oddgeir L. Holmen
  • Marylyn D. Ritchie
  • David H. Ledbetter
  • Andrew J. Murphy
  • Ingrid B. Borecki
  • Jeffrey G. Reid
  • John D. Overton
  • Ola Hansson
  • Leif Groop
  • Svati H. Shah
  • William E. Kraus
  • Daniel J. Rader
  • Yii Der I. Chen
  • Kristian Hveem
  • Nicholas J. Wareham
  • Sekar Kathiresan
  • Olle Melander
  • Kari Stefansson
  • Børge G. Nordestgaard
  • Anne Tybjærg-Hansen
  • Goncalo R. Abecasis
  • David Altshuler
  • Jose C. Florez
  • Michael Boehnke
  • Mark I. McCarthy
  • George D. Yancopoulos
  • David J. Carey
  • Alan R. Shuldiner
  • Aris Baras
  • Frederick E. Dewey
  • Jesper Gromada
View graph of relations

Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that loss of ANGPTL4 function might improve glucose homeostasis and decrease risk of type 2 diabetes (T2D). We investigate protein-altering variants in ANGPTL4 among 58,124 participants in the DiscovEHR human genetics study, with follow-up studies in 82,766 T2D cases and 498,761 controls. Carriers of p.E40K, a variant that abolishes ANGPTL4 ability to inhibit lipoprotein lipase, have lower odds of T2D (odds ratio 0.89, 95% confidence interval 0.85-0.92, p = 6.3 × 10-10), lower fasting glucose, and greater insulin sensitivity. Predicted loss-of-function variants are associated with lower odds of T2D among 32,015 cases and 84,006 controls (odds ratio 0.71, 95% confidence interval 0.49-0.99, p = 0.041). Functional studies in Angptl4-deficient mice confirm improved insulin sensitivity and glucose homeostasis. In conclusion, genetic inactivation of ANGPTL4 is associated with improved glucose homeostasis and reduced risk of T2D.

Original languageEnglish
Article number2252
JournalNature Communications
Volume9
Issue number1
Pages (from-to)2252
ISSN2041-1723
DOIs
Publication statusPublished - 1 Dec 2018

ID: 55678524